Found 3754 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)
PHASE1Primary trial objective in this single arm trial is to assess the safety an...
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
PHASE2The goal of this single-arm, Phase II interventional clinical trial is to t...
Location
West China Hospital, Sichuan University
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
N/ALung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
PHASE2This is a single arm Phase II study, in which 6 cycles of durvalumab with c...
Location
Beijing Haidian Hospital
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
PHASE2This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Location
M D Anderson Cancer Center
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma
PHASE2The investigators conducted a phase II, prospective, two-arm clinical study...
Location
Fujian Medical University Union Hospital
Using ctDNA to Determine Therapies for Lung Cancer
PHASE2This is a study to look at whether the presence of circulating tumour DNA (...
Location
Princess Margaret Cancer Centre
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
PHASE1GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Location
GSK Investigational Site
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
PHASE2This is a prospective, multi-center, single arm study assessing the efficac...
Location
Henan Cancer Hospital